Home / Companies / News / Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22

drug, medicine, drugs, pharma, pharmaceutical

Premium

Anti-infectives have seen a spike from 35 days on March 22 to 62 days on April 22. Dermatology has seen a rise from 43 days to 61 days, whereas vaccines have seen a sharp rise in inventory from 27 days to 69 days as India’s immunisation drive was par

Sohini Das Mumbai

4 min read Last Updated : Apr 28 2020 | 11:17 PM IST

In what may be considered as early signs of slowing down, the domestic pharmaceutical industry’s inventory lying with trade has gone up since the nationwide lockdown was announced on March 24. Industry insiders say the pharma industry is expected to clock 1-3 per cent overall growth this year.

At an overall level, the inventory days have gone up from 31 days as on March 22 to 41 days as on April 22, showed the data from market research firm AIOCD AWACS. The first month of the nationwide lockdown has seen lower offtake of medicines across the country. Barring chronic therapy,

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in